MedTrace Logo

FreeDom: Innovative Strategy for the Management of COPD Exacerbations

NCT03396172 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-06-18

No results posted yet for this study

Summary

The main objective of the study is to assess the "FreeDom" innovative strategy (FreeO2 at Domicile) to reduce hospitalization duration in patients with COPD exacerbation. This strategy associates early hospital discharge, automated O2 flow weaning with FreeO2 system, telemedicine and tele-rehabilitation.

The main hypothesis of this study is that the FreeDom strategy will reduce the number of hospitalization day by 50 percent at day 30.

Conditions

  • Oxygen Deficiency
  • COPD Exacerbation

Interventions

OTHER

Control

The hospitalization will take place in the usual setting and the hospital discharge will be decided by pulmonologists according to the usual criteria

DEVICE

FreeDom

Early return home, patients using an innovative device that automatically adjusts and wean the oxygen flow (FreeO2 system) coupled to telemedicine and tele-rehabilitation

Sponsors & Collaborators

  • Laval University

    lead OTHER

Principal Investigators

  • François Lellouche · Laval University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-24
Primary Completion
2025-06-30
Completion
2025-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03396172 on ClinicalTrials.gov